EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Atypia of undetermined significance and ThyroSeq v3–positive call rates as quality control metrics for cytology laboratory performance

Odille Mejia-Mejia, Andres Bravo-Gonzalez, Monica Sanchez-Avila, Youley Tjendra iD, Rodrigo Santoscoy, Katherine Drews-Elger, Yiqin Zuo, Camilo Arias-Abad, Carmen Gomez, Monica Garcia-Buitrago, Mehrdad Nadji, Merce Jorda und 2 weitere

Cancer Cytopathology · 2024

DOI: 10.1002/cncy.22821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Odille Mejia-Mejia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Miller School of Medicine, University of Miami, Miami, Florida, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Quality Control. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) recommends an upper limit of 10% for atypia of undetermined significance (AUS). Recent data suggest that this category might be overused when the rate of cases with molecular positive results is low. As a quality metric, the AUS and positive call rates for this facility’s cytology laboratory and each cytopathologist (CP) were calculated.

Methods

A retrospective analysis of all thyroid cytology cases in a 4.5‐year period was performed. Cases were stratified by TBSRTC, and molecular testing results were collected for indeterminate categories. The AUS rate was calculated for each CP and the laboratory. The molecular positive call rate (PCR) was calculated with and without the addition of currently negative to the positive results obtained from the ThyroSeq report.

Results

A total of 7535 cases were classified as nondiagnostic, 7.6%; benign, 69%; AUS, 17.5%; follicular neoplasm/suspicious for follicular neoplasm, 1.4%; suspicious for malignancy, 0.7%; and malignant, 3.8%. The AUS rate for each CP ranged from 9.9% to 36.8%. The overall PCR was 24% (range, 13%–35.6% per CP). When including cases with currently negative results, the PCR increased to 35.5% for the cytology laboratory (range, 13%–42.6% per CP). Comparison analysis indicates a combination of overcalling benign cases and, less frequently, undercalling of higher TBSRTC category cases.

Conclusions

The AUS rate in the context of PCR is a useful metric to assess cytology laboratory and cytopathologists’ performance. Continuous feedback on this metric could help improve the overall quality of reporting thyroid cytology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsQuality ControlHumansRetrospective StudiesBiopsy, Fine-NeedleCytodiagnosisThyroid GlandThyroid NoduleAdenocarcinoma, Follicular

Stichwörter der Autor:innen

Bethesda systemcytopathologist performancemolecular testingquality controlthyroid cytology

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Miller School of Medicine, University of Miami, Miami, Florida, USA.
  • CES University School of Medicine, Medellín, Colombia.
  • Jackson Memorial Hospital, Miami, Florida, USA.
  • Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida, USA.
  • Departamento de Matematicas, Universidad Nacional de Colombia, Medellín, Colombia.

ORCID-Profile: Youley Tjendra, Jaylou M Velez-Torres

Zitieren

APA

Mejia-Mejia, O., Bravo-Gonzalez, A., Sanchez-Avila, M., Tjendra, Y., Santoscoy, R., Drews-Elger, K., Zuo, Y., Arias-Abad, C., Gomez, C., Garcia-Buitrago, M., Nadji, M., Jorda, M., Velez-Torres, J. M., & Ruiz-Cordero, R. (2024). Atypia of undetermined significance and ThyroSeq v3–positive call rates as quality control metrics for cytology laboratory performance. Cancer Cytopathology. https://doi.org/10.1002/cncy.22821

Vancouver

Mejia-Mejia O, Bravo-Gonzalez A, Sanchez-Avila M, Tjendra Y, Santoscoy R, Drews-Elger K, et al. Atypia of undetermined significance and ThyroSeq v3–positive call rates as quality control metrics for cytology laboratory performance. Cancer Cytopathology. 2024. doi:10.1002/cncy.22821

BibTeX
@article{MejiaMejia2024,
  author = {Mejia-Mejia, Odille and Bravo-Gonzalez, Andres and Sanchez-Avila, Monica and Tjendra, Youley and Santoscoy, Rodrigo and Drews-Elger, Katherine and Zuo, Yiqin and Arias-Abad, Camilo and Gomez, Carmen and Garcia-Buitrago, Monica and Nadji, Mehrdad and Jorda, Merce and Velez-Torres, Jaylou M and Ruiz-Cordero, Roberto},
  title = {Atypia of undetermined significance and ThyroSeq v3–positive call rates as quality control metrics for cytology laboratory performance},
  journal = {Cancer Cytopathology},
  year = {2024},
  doi = {10.1002/cncy.22821}
}
Kostenlos starten →